Form 4: Veracyte Executive John Leite Reports Stock Transaction
SEC Form 4 Filing
John Leite, Chief Commercial Officer-CLIA of Veracyte, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On June 2, 2024, John Leite, Chief Commercial Officer-CLIA of Veracyte, Inc., reported a transaction involving common stock.
- The transaction involved the withholding of 1,314 shares to satisfy tax obligations related to the vesting of restricted stock units.
- The price per share was $20.75.
- Following the transaction, Leite beneficially owns 84,245 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no indication of positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates activity related to compensation and tax obligations, which is typical for executives receiving stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| 09/01/2022 | Date of grant for 1,606 Restricted Stock Units. |
| 03/06/2023 | Date of grant for 985 Restricted Stock Units. |
| 06/02/2024 | Date of transaction (stock withholding). |
| 06/04/2024 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.